Yanzheng Liu
Senior Director - Quality Control Aspen Neuroscience
Yanzheng Liu is a seasoned Senior Director in Cell and Gene Therapy Analytical Development and Quality Control (ADQC), bringing over 20 years of expertise in biopharmaceuticals. Currently, she leads quality control efforts for Aspen Neuroscience, Inc., when she oversees critical quality control operations for iPSC-based therapies. Prior to joining Aspen, she established and led ADQC functions at Sorrento Therapeutics for oncolytic immunotherapy manufacturing. Prior to Sorrento she held various positions of increasing responsibility at MilliporeSigma. Yanzheng Liu has a Ph.D. in microbiology and immunology.
Seminars
Wednesday 9th September 2026
Roundtable: Implementing Functional QC Frameworks to Predict Potency & Reduce Line-to- Line Variability Early in Development
11:30 am
- Using functional assays to assess differentiation, proliferative potential and therapeutic relevance early, reducing downstream manufacturing and clinical failure risk
- Addressing the industry-wide gap in functional characterization defining what must be measured preclinically to ensure products are safe
- Building QC systems that de-risk variability across clones, donors, and maturation states, ensuring controlled, predictable behavior before entering GMP workflows
